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and emotional constructs. Confirmatory analysis suggests that both the original 
seven factor model, and a model splitting MH and VT based on the direction of the 
items, fit the data acceptably. ConClusions: There is evidence for cross cultural 
differences in the role functioning dimensions of the SF-36, most likely due to dif-
ferences in the perception of emotional health. The inconsistency of the MH and 
VT dimensions may be due to the combination of positive and negative items, order 
effects, or content overlap.
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objeCtives: The Patient-Reported Outcome Measurement Information System 
(PROMIS), funded by the National Institute of Health (NIH) is a large database of 
precise measures of patient-reported health status for physical, mental, and social 
well-being. Use of the PROMIS tools to evaluate humanistic outcomes in hospital-
ized patients with Clostridium difficile infection (CDI) has not been studied. The 
objective of this study was to identify and validate the use of specific PROMIS 
network questions to evaluate patient-reported health status associated with 
CDI. Methods: This was a prospective, observational, two-center, mixed-methods 
study. Hospitalized adult patients with CDI were interviewed within seven days of 
a positive toxin test for C. difficile and again within one week of hospital discharge 
(N = 40). Patients were asked open-ended questions regarding their top three 
concerns related to CDI. Results were analyzed using ATLAS.ti 7 and classified by 
PROMIS domains. Based on response trends, applicable standardized questions 
from the PROMIS network were identified. An additional 15 patients with CDI were 
interviewed using the PROMIS questions to validate relevant questions. Results: 
Patient reported humanistic outcomes within seven days of CDI diagnosis were 
primarily associated with mental concerns (75%) related to anxiety and worry 
about future complications. Physical concerns (8%) were related to ongoing diar-
rhea, bowel incontinence and other abdominal complaints. Social concerns (3%) 
included interference with daily living and finances. Patient reported outcome 
responses did not change significantly during the follow-up interview. Using these 
responses from direct interviews of CDI patients, 18 PROMIS network questions 
were identified and demonstrated evidence of reliability. ConClusions: Using 
the NIH PROMIS network, we identified 18 patient-reported health status ques-
tions that can be used to evaluate humanistic outcomes in patients with CDI. 
Future studies should use these questions to assess changes in health status of 
CDI patients over time.
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objeCtives: The EQ-5D is a preference-based measure of health for economic 
evaluation. This study is to develop a Hong Kong (HK) Chinese version of EQ-5D-5L 
and value set in estimating the health utility in local population. Methods: This 
study consists of three parts including (I) Translation and Cultural Adaptation of 
the HK Chinese version of EQ-5D-5L by forward/backward translation and lay panel 
assessment; (II) Valuation Study of EQ-5D-5L HK by a cross-sectional population-
based survey; and (III) Creation of norms values in HK by secondary analysis of 
data from part II study. 20 respondents and 1,000 respondents aged ≥ 18years old 
will be recruited for part I and II study respectively. Subjects are quota sampled 
by geographic area and demographic characteristics (gender, age and education 
level) based on the comparison of HK population in the HK Census 2011. Results: 
In part I: Forward/backward translation of the English version of EQ-5D-5L are 
performed based on the translation protocol of the EuroQol group, cognitive 
interview with 20 laymen which are conducted for cultural adaption of the HK 
Chinese version of EQ-5D-5L. The HK Chinese version of EQ-5D-5L (EQ-5D-5L HK) 
is validated. In part II: A total of 475 out of 1000 subjects were recruited for face-
to-face interviews with computer-assisted using EQ-5D-5L HK. The sample (38.9% 
in 18-44 yrs; 36.6% in 45-64 yrs; 24.4% in 65 yrs and above) was predominantly 
female and with a secondary education level. ConClusions: A preference-based 
values using EQ-5D-5L HK are to be collected from the general population in HK. 
This value set data will then be used to derive an algorithm model to estimate 
the preference-based health index in the Hong Kong population. The norms of 
health-related quality of life in Hong Kong population using EQ-5D-5L will be 
presented by different demographic groups including age, gender and education 
level.
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objeCtives: The main objective of this study was to assess the usability of the 
newly developed web-based UK versions of the Standardised Asthma Quality of 
Life Questionnaire for individuals12 years and older (AQLQ(S)+12) and the Asthma 
Control Questionnaire (ACQ-6). Methods: Individual interviews were conducted 
with eight patients with asthma. During the session, each patient was requested 
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objeCtives: Measurement of the risk-benefit tradeoffs in healthcare decision-
making relies on capturing preferences for treatment attributes that are most 
important to individuals. The goal of this study is to develop and validate a meth-
odological framework for identifying, validating, and prioritizing attributes for 
inclusion in discrete choice experiments (DCE). Methods: The study enrolled 48 
caregivers of a child aged 26 or younger diagnosed with an intellectual disability 
and mental health disorder. Data were collected through IDIs (n= 6) and six focus 
groups (n= 42). Following qualitative methods for grounded theory and content 
analysis, data were analyzed in four distinct steps. First, in-depth interviews 
(IDIs) were analyzed to identify concepts reflecting distinct situations influencing 
treatment decisions. Second, the concepts were validated by researcher-caregiver 
agreement in defining the concept. Third, caregivers prioritized the concepts by 
selecting those that were most influential in making treatment decisions for their 
child. Fourth, a final list of attributes was chosen based on the subset of attrib-
utes that had high researcher-caregiver agreement and that were a high prior-
ity. Triangulation, member checking, and participants’ and stakeholder partners’ 
feedback was used throughout the process. Results: Sixteen concepts were 
identified from the IDIs. Researcher-caregiver agreement in concept definition 
ranged between 21-79%. The concepts rated as high priorities in decision-making 
were managing the child’s behavior, advocating for the child’s needs, and com-
municating with providers. The financial impact and getting a label were low 
priorities in treatment decisions. Seven concepts rated as low priorities and with 
low definition agreement were discarded. This resulted in a final list of nine attrib-
utes. ConClusions: Systematic methods for attribute identification, as well as 
stakeholder involvement, will inform the development of DCE instruments that 
closely reflect risk-benefit tradeoffs in healthcare decisions. Methodological stand-
ards for attribute identification would enhance the application and interpretation 
of DCE in preference elicitation.
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objeCtives: To evaluate the importance of a health-educational interventional 
program to improve Health-Related Quality of Life (HRQoL) among Pulmonary 
Tuberculosis (PTB) patients in Pakistan, under the supervision of registered hospital 
pharmacists. Methods: A health-educational intervention to improve HRQoL was 
offered to the PTB patients through registered hospital pharmacists. In this non-
clinical randomized controlled trial, PTB patients were briefed regarding treatment 
and management of PTB and their HRQoL was measured by WHOQOL-BREF. Both 
descriptive and inferential statistics were used to determine patients’ demographic 
characteristics and inter-group comparisons respectively. Data was analyzed by 
SPSS 21.0. Results: Two hundred and eighty PTB patients were randomly assigned 
for the study i.e. one hundred and forty patients in each group. No significant dif-
ferences were observed in either group for mean age, gender, education level, occu-
pation and income whereas a significant increase (p< 0.001) in the WHOQOL-BREF 
score was observed in the interventional group. ConClusions: HRQoL was signifi-
cantly improved in the interventional group after the pharmacist-led interventional 
program which advocates the vital role of pharmacists in patients’ education and 
a better health care system of Pakistan.
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objeCtives: The SF-36 is a measure of health related quality of life that is widely 
used internationally. SF-36 produces scores for eight dimensions (physical func-
tioning (PF); role physical (RP); bodily pain (BP); general health (GH); vitality (VT); 
social functioning (SF); role emotional (RE); mental health (MH). However there 
is debate about whether these dimensions are applicable cross culturally, and 
also the relationship between the MH and VT dimensions. The aim was to assess 
the dimensionality using multinational datasets as part of the development of 
SF-6D-V2. Methods: Exploratory and confirmatory factor analysis was used to 
examine SF-36 dimensionality, and was applied to patient and general population 
datasets from the UK, Australia, Canada, USA and Japan (n = 55,923). Analysis was 
carried out separately for each country, and on the combined data. The general 
health items were not included as the focus was the specific health areas meas-
ured by SF-36. Results: Exploratory factor analysis on the data from the English 
speaking countries suggests that the PF, RF, BP, SF and RE dimensions are generally 
consistent but there are inconsistencies regarding the MH and VT, where the items 
split into factors based on whether the item is positively or negatively worded. 
The data from Japan suggests that the role dimensions do not split into physical 
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objeCtives: The Short-Form 36 Health Survey version 2.0 (SF-36v2®) is a validated 
patient-reported outcome instrument. A validated single-item format version exists 
for deployment on computer screens/tablet-sized devices, and an electronic hand-
held version was developed in 2012. The objectives of this study were to evaluate 
measurement equivalence between the paper and electronic versions of the SF-36v2 
administered using a handheld device or a smartphone app, and to determine 
patient preference for mode of administration. Methods: This was a randomized 
crossover study in which 101 subjects with type II diabetes completed the SF-36v2 
on two modalities: paper and either the electronic handheld (PHT LogPad® LW) 
or the smartphone App (PHT LogPad App). Subjects completed the assessment in 
a single session with distraction activities between completion of the first and 
second modality and an exit survey which assessed patient preference for mode of 
administration. Results: Study data will be analyzed to test score level equivalence 
and to calculate the intraclass correlation coefficient (ICC) and other measures of 
measurement equivalence. Equivalence analysis is in progress, and findings will 
be ready to present for this meeting. 82% of subjects found the electronic method 
easy to use and 80% found it easy to navigate. Of those subjects who expressed a 
preference, 57% found it more physically comfortable and 69% found it faster to 
complete than paper. 65% would prefer the electronic method over paper when 
responding to questions in a clinical trial. ConClusions: This study will evaluate 
the measurement equivalence between standard paper versions of the SF-36v2 
and electronic handheld versions as deployed on an electronic handheld device or 
a smartphone App. Patients with diabetes generally prefer to complete the SF-36v2 
electronically rather than on paper.
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objeCtives: Angiotensin-converting enzyme inhibitors (ACEI) have been impli-
cated in bradykinin-mediated angioedema. With ever-widening indications for 
ACEI including hypertension, congestive heart failure, diabetic nephropathy, 
etc., a concomitant increase in ACEI-Angioedema (ACEI-A) has been reported. 
At present there is no validated severity scoring or discharge criteria for ACEI-A. 
We sought to develop an investigator rating scale with corresponding discharge 
criteria. This study aimed to confirm the clinical relevance, content validity, and 
reliability of the scale with clinicians experienced in treating ACEI-A. Methods: 
In-depth, 60-minute qualitative telephone interviews were conducted with 12 
US-based emergency physicians. Beforehand, clinicians were sent four case stud-
ies describing patients experiencing different severities of angioedema attacks. 
Clinicians were initially asked open-ended questions about their experience of 
patients’ symptoms, treatment and discharge decisions. Clinicians then rated 
each patient case study and discussed patient diagnoses, ratings of symptom 
severity and discharge evaluation. The ratings were used to assess inter-rater 
reliability of the scale using the intra-class correlation coefficient (ICC) using IBM 
SPSS analysis Version 19 software. Results: The findings provide support for 
focus on the four key symptoms of airway compromise scored on a 0-4 scale: 
1) Difficulty Breathing, 2) Difficulty Swallowing, 3) Voice Changes and 4) Tongue 
Swelling and the corresponding discharge criteria of a score of 0 or ‘No symptoms’ 
for Difficulty Breathing and Difficulty Swallowing and a score of 0 or 1 indicat-
ing mild or absence of symptoms for Voice Change and Tongue Swelling. Eleven 
clinicians agreed the absence of standardized discharge criteria supported the 
use of the scale and all physicians concurred with the recommended discharge 
criteria. The clinician ratings provided evidence of strong inter-rater reliability 
for the rating scale (ICC> 0.80). ConClusions: The investigator rating scale and 
discharge criteria are clinically valid, relevant and reliable. Moreover, both address 
the current unmet need for standardized discharge criteria.
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objeCtives: sIBM is a progressive idiopathic inflammatory myopathy characterized 
by the asymmetric atrophy and weakness of proximal and distal muscle groups. 
Atrophy of the quadriceps, wrist, and finger flexor muscles and dysphagic pro-
cesses are clinical hallmarks and result in significant functional disabilities with 
progression. To understand impact on patients, a qualitative study was conducted to 
support the development of a disease model depicting relationships among patient 
concepts relevant to disease progression that may be impacted by the treatment of 
sIBM. No such disease model is currently available. Methods: A literature review 
was conducted to determine a preliminary understanding of the impact of sIBM. 
This was followed by therapeutic area expert input and interviews of patients diag-
nosed with sIBM (n = 20). Based on all results, a model was constructed. Results: 
Results from literature and expert input allowed for the development of an initial 
diagram depicting a proposed pathway from a diagnosis of sIBM, modifying factors 
(e.g. age, gender, duration, severity, falls), proximal concepts of signs and symptoms 
of disease (weakness, atrophy), functioning (upper extremity, lower extremity, gen-
eral, swallowing) and through more distal psychosocial concepts (emotions, mood, 
relationships). Patient feedback was used to further refine the model. Some physical 
1) to fill in the questionnaire online, focusing on the instructions developed for 
online use; 2) to comment on their understanding of the instructions and suggest 
alternative formulations in case of problematic wording; and 3) to comment on 
the online administration and handiness of the version on the device (i.e., leg-
ibility of the instructions and items/response choices). After the test session, the 
interviewer asked questions about easiness of completion, navigation, instruc-
tions, screen and font size, and also reported on any hesitations or questions 
asked by the patient during the process. The severity of the issues encountered 
during the test was divided into three levels with level 1 indicating inability of 
use and/or incomprehensibility of instructions. Results: All respondents were 
able to answer the questions on their own without help. The respondents found 
the instructions very clear, and completing the online versions of the instruments 
proved to be easy and quick. For those who wished to correct their answers, going 
back to the previous screens was also easy. Minor changes were suggested to the 
screen resolution, font size of the response choices of the AQLQ(S)+12, and to 
the background colour. It was also suggested the number of questions should be 
included on the first screen. The online versions were revised accordingly. All par-
ties involved agreed that there was no need for further testing. ConClusions: 
The web-based UK versions of the AQLQ(S)+12 and (ACQ-6) proved to be easy to 
use and understandable with minor improvements.
PRM103
DeveloPMent AnD content vAliDity of A PeDiAtRic functionAl 
constiPAtion DAily DiARy
Turner-Bowker D.M.1, Lindner E.2, Mareya S.2, Losch-Beridon T.2, Elash C.A.1, Paty J.3,  
Keithly S.4, Ascoytia C.4
1ERT, Pittsburgh, PA, USA, 2Sucampo Pharma Americas LLC, Bethesda, MD, USA, 3Quintiles, 
Hawthorne, NY, USA, 4Health Research Associates, Mountlake Terrace, WA, USA
objeCtives: To demonstrate how patient and parent/legal guardian interviews 
reinforce a conceptual model of pediatric functional constipation signs, symp-
toms, and impact for inclusion in a Pediatric Functional Constipation Daily Diary 
(PFC-DD); and to evaluate patient and parent/legal guardian comprehension and 
usability of the PFC-DD administered via electronic diary. Methods: Qualitative 
patient interviews were conducted with pediatric patients who have functional 
constipation and their parent/legal guardian to determine the most important 
and relevant signs, symptoms, and impacts associated with the condition, and 
to evaluate comprehension and usability of the draft PFC-DD. Concept elicitation 
(CE) and cognitive interviews (CI) were conducted with the parent/legal guardian 
of children ages 6 months to < 6 years (CE, n= 18; CI, n= 11), and with children/
adolescents ages 6 to < 18 years and their parent/legal guardian (CE, n= 18; CI 
patient n= 21, parent n= 20). Results: For both groups, the predominant sign/
symptom concepts reported were: stool consistency changes, toileting avoidance 
and/or retentive posturing, child report and/or behaviors suggesting abdominal 
pain, difficulty while toileting (e.g., straining, rectal pain), infrequent bowel move-
ments, and appetite changes. Parents of children ages 6 months to < 6 years also 
reported abdominal hardness, gas, and soiling. The predominant impacts reported 
were limitations in physical activity, emotional and social function, sleep (younger 
age group only), school participation (older age group only), and coping strategies 
(e.g., medications/supplements). Results from the CIs indicated no comprehension 
problems for most items. However, minor revisions (e.g., definition for ‘reten-
tive posturing’) were made to the wording of a few items to improve clarity and 
appropriate understanding of the concept. No concerns were raised about the 
usability of the electronic diary. ConClusions: Findings support the content 
validity of the PFC-DD, a new instrument that includes PRO and ObsRO items to 
assess the key signs, symptoms, and impacts experienced by pediatric patients 
with functional constipation.
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issues ResolveD DuRing the linguistic vAliDAtion of A BehAviouRAl 
scAle
Williams H., Oke L., Scharf L., Anderson H., Gergovich B.
ICON Plc, Oxford, UK
objeCtives: (1) To identify the translation issues during linguistic validation of 
a behavioural scale, (2) to ascertain whether the same issues appeared in more 
than one language, (3) to determine what solutions were found to ensure con-
ceptual accuracy, with a view to collecting consistently valid data across the 
study. Methods: 28 back translation and psychologist reviews of a behavioural 
scale were examined, in which translation issues had been discussed at length 
between lead translators, project managers and experts in the field. Information 
was gathered on the translation difficulties that arose in each language and the 
results were compared in order to identify patterns. Results: Three main cat-
egories of discussion were identified: Transferral of word length and complexity 
was particularly important. Literal translations needed replacing with culturally 
adapted wording across a high percentage of the languages to ensure overall 
conceptual equivalence. Many idioms and common phrases were found to be non-
sensical when translated literally. Across all languages, expressions like ‘Button 
your lip’ and ‘Hit the road’ were replaced with localised sayings that would enable 
conceptual comprehension of the items. Questions regarding grammar and tense 
led to alterations and omissions in a number of languages due to dramatic dif-
ferences in language structure across the world. In questions regarding irregular 
verb use, for example, most languages replaced the examples or removed them 
altogether if no such irregular verbs existed. ConClusions: The behavioural 
scale was found to contain many translation issues arising from its focus on 
language specific distinctions. Patterns were found in the resolution of these 
issues and changes often necessitated moving away from a literal translation 
so that concepts and ideas could be appropriately conveyed. This highlights the 
importance of linguistic validation and its ability to improve translation quality 
for cross-cultural comparison.
